Myth 1: there is one ideal microbiome
A sebaceous T-zone, a drier forearm and a moist fold have different conditions and microbial communities. Research mapping skin topography found a systematic relationship between the physiology of each site and its community structure. What is natural in one area is not a universal norm for another.
“Restoring ideal balance” is therefore too vague a goal. A meaningful promise needs a site, metric and method. In daily care, choose for the area and need — not for an imaginary single correct bacterial profile.
Myth 2: association already proves product action
Researchers have found relationships between facial sebum, hydration and microbial profiles. But two measures changing together does not show that one caused the other. Observation can generate a useful hypothesis; it cannot prove a cosmetic product's effect.
A causal conclusion needs one defined product, a comparison, duration, a preselected metric and analysis of other factors. Without these, “changes the microbiome” is stronger than the evidence.
Myth 3: all “good bacteria” work alike
Early trials of live bacteria examined specific strains and doses, often in atopic dermatitis. Roseomonas mucosa was explored in an open-label study without a control group. ShA9 was tested in a randomised design: S. aureus burden fell, while overall eczema severity did not differ statistically from control.
These are important scientific questions, not universal advertising for cosmetics. They show why strain, dose, population, duration and endpoint must all be specified. “With bacteria” is not enough.
Myths 4 and 5: a label word or testimonial replaces evidence
A bacterial name, ferment or lysate describes a component; it does not guarantee the performance of the formula. A compelling testimonial describes one person's experience; it does not establish cause for everyone.
Look for the finished product, application site, analytical method, metric, control and duration. Ask whether the study measured community composition, one microorganism, barrier function or perceived comfort. These outcomes are different and cannot be silently exchanged.
SAVE BEFORE YOU BUY
Your quick checklist
- Is the exact skin area named?
- Was composition, barrier, comfort or a symptom measured?
- Was the finished product studied?
- Were there a control and meaningful duration?
- Is a testimonial being used instead of evidence?
Sources
Direct links to the research and documents used in this article. They correspond to the numbered citations above.
- Grice EA et al. Topographical and temporal diversity of the human skin microbiome. Science, 2009.
- Oh J et al. Temporal stability of the human skin microbiome. Cell, 2016.
- Mukherjee S et al. Sebum and hydration are associated with facial microbiome patterns. Scientific Reports, 2016.
- Myles IA et al. First-in-human topical Roseomonas mucosa study in atopic dermatitis. JCI Insight, 2018.
- Nakatsuji T et al. First-in-human trial of topical ShA9 in atopic dermatitis. Nature Medicine, 2021.